96 results
Page 2 of 5
8-K
EX-99.1
btzuw4rplvybcr 3i
4 May 21
Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021
4:07pm
8-K
EX-4.1
52q1n64yrtoou 3kre
8 Apr 21
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-10.1
p18g1w16d1kvwlml4
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
8-K
EX-1.1
n8tsh5esqccxh9agwp
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
3qwn8bxo2tvf56u6
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
9mmgvq1y
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
m3tm sip2ptgi
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
1ncnf66
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.3
hy6wfxv7qanpm5x3czfz
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
sfy0qzcg
28 Aug 20
Prospectus supplement
4:31pm
425
jg5drkm
24 Jun 20
Business combination disclosure
5:11pm